D. B. Carr and S. R. Sesack, Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals, J Comp Neurol, vol.369, issue.1, pp.1-15, 1996.

C. R. Gerfen, The neostriatal mosaic: multiple levels of compartmental organization, J Neural Transm Suppl, vol.36, pp.43-59, 1992.

P. Calabresi, B. Picconi, A. Tozzi, D. Filippo, and M. , Dopamine-mediated regulation of corticostriatal synaptic plasticity, Trends Neurosci, vol.30, issue.5, pp.211-219, 2007.

D. Centonze, Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism, Neuroscience, vol.133, issue.3, pp.831-840, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00118706

T. N. Chase, J. D. Oh, and S. Konitsiotis, Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms, J Neurol, vol.247, issue.2, pp.36-42, 2000.

S. Fahn, How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?, Ann Neurol, vol.64, issue.2, pp.56-64, 2008.

J. A. Obeso, The origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits, Neurology, vol.62, issue.1, pp.17-30, 2004.

O. Rascol, Medical treatment of levodopa-induced dyskinesias, Ann Neurol, vol.47, pp.179-188, 2000.

B. Picconi, Abnormal Ca2+-calmodulindependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism, J Neurosci, vol.24, issue.23, pp.5283-5291, 2004.

F. Gardoni, D. Luca, and M. , New targets for pharmacological intervention in the glutamatergic synapse, Eur J Pharmacol, vol.545, issue.1, pp.2-10, 2006.

P. J. Hallett, R. Spoelgen, B. T. Hyman, D. G. Standaert, and A. W. Dunah, Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking, J Neurosci, vol.26, issue.17, pp.4690-4700, 2006.

S. Robelet, C. Melon, B. Guillet, P. Salin, K. Goff et al., Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease, Eur J Neurosci, vol.20, issue.5, pp.1255-1266, 2004.

H. S. Lindgren, D. R. Andersson, S. Lagerkvist, H. Nissbrandt, and M. A. Cenci, L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia, J Neurochem, vol.112, issue.6, pp.1465-1476, 2010.

A. Berthet, Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia, J Neurosci, vol.29, issue.15, pp.4829-4835, 2009.

C. Guigoni, E. Doudnikoff, Q. Li, B. Bloch, and E. Bezard, Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates, Neurobiol Dis, vol.26, issue.2, pp.452-463, 2007.

P. J. Hallett, Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease, Neuropharmacology, vol.48, issue.4, pp.503-516, 2005.

M. A. Silverdale, Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate, Synapse, vol.64, issue.2, pp.177-180, 2010.

I. Aubert, Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia, Ann Neurol, vol.57, issue.1, pp.17-26, 2005.

B. Picconi, Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia, Nat Neurosci, vol.6, issue.5, pp.501-506, 2003.

E. Santini, Critical involvement of cAMP/ DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia, J Neurosci, vol.27, issue.26, pp.6995-7005, 2007.

J. E. Westin, L. Vercammen, E. M. Strome, C. Konradi, and M. A. Cenci, Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPAinduced dyskinesia and the role of dopamine D1 receptors, Biol Psychiatry, vol.62, issue.7, pp.800-810, 2007.

E. Santini, Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia, PloS One, vol.5, issue.8, p.12322, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00628011

M. A. Cenci and H. S. Lindgren, Advances in understanding L-DOPA-induced dyskinesia, Curr Opin Neurobiol, vol.17, issue.6, pp.665-671, 2007.

M. A. Cenci and M. Lundblad, Post-versus presynaptic plasticity in L-DOPA-induced dyskinesia, J Neurochem, vol.99, issue.2, pp.381-392, 2006.

M. R. Ahmed, Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease, Sci Transl Med, vol.2, issue.28, pp.28-28, 2010.

C. Fiorentini, F. Gardoni, P. Spano, D. Luca, M. Missale et al., Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors, J Biol Chem, vol.278, issue.22, pp.20196-20202, 2003.

W. D. Yao, R. D. Spealman, and J. Zhang, Dopaminergic signaling in dendritic spines, Biochem Pharmacol, vol.75, issue.11, pp.2055-2069, 2008.

J. Zhang, PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex, J Neurosci, vol.29, issue.9, pp.2948-2960, 2009.

J. E. Nash, T. H. Johnston, G. L. Collingridge, C. C. Garner, and J. M. Brotchie, Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPAinduced dyskinesia, FASEB J, vol.19, issue.6, pp.583-585, 2005.

E. Bezard, J. M. Brotchie, and C. E. Gross, Pathophysiology of levodopa-induced dyskinesia: potential for new therapies, Nat Rev Neurosci, vol.2, issue.8, pp.577-588, 2001.

P. Jenner, Molecular mechanisms of L-DOPAinduced dyskinesia, Nat Rev Neurosci, vol.9, issue.9, pp.665-677, 2008.

A. Berthet and E. Bezard, Dopamine receptors and L-dopa-induced dyskinesia. Parkinsonism Relat Disord, vol.15, pp.8-12, 2009.

M. A. Cenci, C. S. Lee, and A. Bjorklund, L-DOPAinduced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA, Eur J Neurosci, vol.10, issue.8, pp.2694-2706, 1998.

M. Lundblad, M. Andersson, C. Winkler, D. Kirik, N. Wierup et al., Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease, Eur J Neurosci, vol.15, issue.1, pp.120-132, 2002.

C. Lois, E. J. Hong, S. Pease, E. J. Brown, and D. Baltimore, Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors, Science, vol.295, issue.5556, pp.868-872, 2002.

O. M. Schluter, W. Xu, and R. C. Malenka, Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function, Neuron, vol.51, issue.1, pp.99-111, 2006.

S. Fasano, Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia, Proc Natl Acad Sci, vol.107, issue.50, pp.21824-21829, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055134

M. Vila, Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA, J Neurosci, vol.17, issue.2, pp.765-773, 1997.

M. Vila, Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements, Eur J Neurosci, vol.12, issue.1, pp.337-344, 2000.

T. Boraud, E. Bezard, B. Bioulac, and C. E. Gross, Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey, Brain, vol.124, pp.546-557, 2001.

W. Meissner, Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine, Neurobiol Dis, vol.22, issue.3, pp.586-598, 2006.

J. Zhang, Inhibition of the dopamine D1 receptor signaling by PSD-95, J Biol Chem, vol.282, issue.21, pp.15778-15789, 2007.

C. G. Goetz, W. Poewe, O. Rascol, and C. Sampaio, Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease, Mov Disord, vol.20, issue.5, pp.523-539, 2001.

D. Rylander, A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys, Neurobiol Dis, vol.39, issue.3, pp.352-361, 2010.

A. Carlsson, N. Waters, S. Holm-waters, J. Tedroff, M. Nilsson et al., Interactions between monoamines, glutamate, and GABA in schizophrenia: New Evidence, Annu Rev Pharmacol Toxicol, vol.41, pp.237-260, 2001.

M. B. Kennedy, Signal-processing machines at the postsynaptic density, Science, vol.290, issue.5492, pp.750-754, 2000.

E. Kim and M. Sheng, PDZ domain proteins of synapses, Nat Rev Neurosci, vol.5, issue.10, pp.771-781, 2004.

L. Groc, Surface trafficking of neurotransmitter receptor: comparison between single-molecule/quantum dot strategies, J Neurosci, vol.27, issue.46, pp.12433-12437, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01553048

A. Triller and D. Choquet, New concepts in synaptic biology derived from single-molecule imaging, Neuron, vol.59, issue.3, pp.359-374, 2008.

W. D. Yao, Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity, Neuron, vol.41, issue.4, pp.625-638, 2004.

E. Bezard, C. E. Gross, L. Qin, V. V. Gurevich, J. L. Benovic et al., L-DOPA reverses the MPTPinduced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain, Neurobiol Dis, vol.18, issue.2, pp.323-335, 2005.

R. T. Premont and R. R. Gainetdinov, Physiological roles of g protein-coupled receptor kinases and arrestins, Annu Rev Physiol, vol.69, pp.511-534, 2007.

V. Bernard, M. Decossas, I. Liste, and B. Bloch, Intraneuronal trafficking of G-protein-coupled receptors in vivo, Trends Neurosci, vol.29, issue.3, pp.140-147, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00297296

F. Gardoni, A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia, J Neurosci, vol.26, issue.11, pp.2914-2922, 2006.

V. Paille, Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition, J Neurosci, vol.30, issue.42, pp.14182-14193, 2010.

C. Tardin, L. Cognet, C. Bats, B. Lounis, and D. Choquet, Direct imaging of lateral movements of AMPA receptors inside synapses, EMBO J, vol.22, issue.18, pp.4656-4665, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00143981

M. C. Ashby, S. R. Maier, A. Nishimune, and J. M. Henley, Lateral diffusion drives constitutive exchange of AMPA receptors at dendritic spines and is regulated by spine morphology, J Neurosci, vol.26, issue.26, pp.7046-7055, 2006.

A. J. Borgdorff and D. Choquet, Regulation of AMPA receptor lateral movements, Nature, vol.417, issue.6889, pp.649-653, 2002.

L. Groc, Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors, Nat Neurosci, vol.7, issue.7, pp.695-696, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01551916

L. Groc, NMDA receptor surface mobility depends on NR2A-2B subunits, Proc Natl Acad Sci, vol.103, issue.49, pp.18769-18774, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01552913

M. Dahan, S. Levi, C. Luccardini, P. Rostaing, B. Riveau et al., Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking, Science, vol.302, issue.5644, pp.442-445, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00002449

J. Meier, C. Vannier, A. Serge, A. Triller, and D. Choquet, Fast and reversible trapping of surface glycine receptors by gephyrin, Nat Neurosci, vol.4, issue.3, pp.253-260, 2001.

C. Bouzigues and M. Dahan, Transient directed motions of GABA(A) receptors in growth cones detected by a speed correlation index, Biophys J, vol.92, issue.2, pp.654-660, 2007.

O. Hegener, L. Prenner, F. Runkel, S. L. Baader, J. Kappler et al., Dynamics of beta2-adrenergic receptor-ligand complexes on living cells, Biochemistry, vol.43, issue.20, pp.6190-6199, 2004.

R. M. Lober, M. A. Pereira, and N. A. Lambert, Rapid activation of inwardly rectifying potassium channels by immobile G-protein-coupled receptors, J Neurosci, vol.26, issue.48, pp.12602-12608, 2006.

L. Scott, Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines, Proc Natl Acad Sci, vol.103, issue.3, pp.762-767, 2006.

F. J. Lee, Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor, Cell, vol.111, issue.2, pp.219-230, 2002.

C. Fiorentini, Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat, Mol Pharmacol, vol.69, issue.3, pp.805-812, 2006.

L. Verhagen-metman, D. Dotto, P. Van-den-munckhof, P. Fang, J. Mouradian et al., Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease, Neurology, vol.50, issue.5, pp.1323-1326, 1998.

H. Sawada, Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial, PLoS One, vol.5, issue.12, p.15298, 2010.

S. R. Schwarze, A. Ho, A. Vocero-akbani, and S. F. Dowdy, In vivo protein transduction: delivery of a biologically active protein into the mouse, Science, vol.285, issue.5433, pp.1569-1572, 1999.

Y. H. Jo, E. Donier, A. Martinez, M. Garret, E. Toulme et al., Cross-talk between P2X4 and gamma-aminobutyric acid, type A receptors determines synaptic efficacy at a central synapse, J Biol Chem, vol.286, issue.22, pp.19993-20004, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01146571

S. Schuster, The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease, J Neurosci, vol.28, issue.17, pp.4311-4316, 2008.

G. E. Torres, R. R. Gainetdinov, and M. G. Caron, Plasma membrane monoamine transporters: structure, regulation and function, Nat Rev Neurosci, vol.4, issue.1, pp.13-25, 2003.

M. Olsson, G. Nikkhah, C. Bentlage, and A. Bjorklund, Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test, J Neurosci, vol.15, issue.5, pp.3863-3875, 1995.

E. Y. Pioli, W. Meissner, R. Sohr, C. E. Gross, E. Bezard et al., Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats. Neuroscience, vol.153, pp.1213-1224, 2008.

C. Winkler, D. Kirik, A. Bjorklund, and M. A. Cenci, L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function, Neurobiol Dis, vol.10, issue.2, pp.165-186, 2002.

E. Bezard, Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease, J Neurosci, vol.21, issue.17, pp.6853-6861, 2001.

C. Guigoni, Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors, Parkinsonism Relat Disord, vol.11, issue.1, pp.25-29, 2005.

S. Schuster, Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia, Biol Psychiatry, vol.65, issue.6, pp.518-526, 2009.

M. W. Pfaffl, G. W. Horgan, and L. Dempfle, Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR, Nucleic Acids Res, vol.30, issue.9, p.36, 2002.

E. Bezard, Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nat Med, vol.9, issue.6, pp.762-767, 2003.

E. Bezard, Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease, J Neurosci, vol.21, issue.17, pp.6853-6861, 2001.

P. O. Fernagut, Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys, PLoS One, vol.5, issue.11, p.14053, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055105

S. J. Gold, RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease, J Neurosci, vol.27, issue.52, pp.14338-14348, 2007.

I. Caille, B. Dumartin, L. Moine, C. Begueret, J. Bloch et al., Ontogeny of the D1 dopamine receptor in the rat striatonigral system: an immunohistochemical study, Eur J Neurosci, vol.7, issue.4, pp.714-722, 1995.

C. Kowalski and P. Giraud, Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures, Neuroscience, vol.53, issue.3, pp.665-672, 1993.

M. Martin-negrier, G. Charron, and B. Bloch, Agonist stimulation provokes dendritic and axonal dopamine D(1) receptor redistribution in primary cultures of striatal neurons, Neuroscience, vol.99, issue.2, pp.257-266, 2000.

M. L. Martin-negrier, G. Charron, and B. Bloch, Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons, Synapse, vol.60, issue.3, pp.194-204, 2006.

C. Bats, L. Groc, and D. Choquet, The interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking, Neuron, vol.53, issue.5, pp.719-734, 2007.

M. Heine, Surface mobility of postsynaptic AMPARs tunes synaptic transmission, Science, vol.320, issue.5873, pp.201-205, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00747627